LAA Closure Associated With Less Bleeds vs. Oral Anticoagulation Post AF Ablation: OPTION
Key Takeaways: The OPTION TRIAL assessed the safety and efficacy of WATCHMAN FLX in a… Continue Reading
Featured NewsView All
Optimization of GDMT Very Modest but Increased Use of MRAs with Audit and Feedback: PHARM-HF A&F Study
Key Points: Over 6 million people in the US live with heart failure (HF), but… Continue Reading
A SUMMIT Analysis: Tirzepatide Reduces End Organ Damage in Patients with Obesity and HFpEF
Key Points SUMMIT, a randomized control trial of tirzepatide versus placebo in patients with HFpEF… Continue Reading
Featured Videos
Featured PodcastsView All
Organizing and Actualizing a Polypharmacy
Dr. Fanikos Speaks at Brigham and Womens’ Hospital
Podcast: Download
Latest Tweets
NewsView All
NUDGE-FLU Pool Analysis: Email Reminders Highlighting CV Benefits of Flu Shots Effective for Increasing Vaccine Uptake Post-MI
Key Points Three prior randomized trials including over two million adults in Denmark demonstrated that… Continue Reading
Edoxaban Comparable to Warfarin After Surgical Bioprosthetic Valves Implantation: ENBALV Trial
Key Points: In patients after surgical bioprosthetic valves, it remains unclear if edoxaban is safe… Continue Reading
PanEcho: AI-Based Automated Image Analysis Improved Quality and Efficiency in Echocardiography
Key Points: Transthoracic echocardiography is foundational to diagnosis and evaluation of myriad conditions, but image… Continue Reading
TOPSPIN- A: Three-Combination of Antihypertensive Meds Provided Similar BP Control
Key Points: The global burden of hypertension (HTN) with high globally at 1.3 billion people… Continue Reading
Personalized App-Based Coaching Improved Physical Activity in HFpEF Patients (MyoMobile Study)
Key Points: Though physical inactivity leads to poor cardiovascular outcomes, especially for those with cardiovascular… Continue Reading
ZODIAC: A Risk-based Decision Support System Did Not Significantly Improve Lipid-Lowering vs Usual Care
Key Points Maximizing lipid lowering therapy (LLTs) to optimize residual cardiovascular disease (CVD) risk after… Continue Reading
